Zevra Therapeutics, Inc. (ZVRA)
NMS – Real Time Price. Currency in USD
11.45
+0.11 (0.97%)
Market open: Aug 12, 2026, 3:42 PM EDT
11.77
+0.43 (3.79%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
11.45
+0.11 (0.97%)
Market open: Aug 12, 2026, 3:42 PM EDT
11.77
+0.43 (3.79%)
Previous after-hours: Aug 11, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $145.3M significantly exceed its total debt $1.5M, ensuring strong financial flexibility
Total current assets $251.3M exceed Total current liabilities $48.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $16.8M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.17 | 6.05 | 10 | |
| Quick ratio | 5.12 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 10 | |
| Weighted average score | 10 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 10M | 27M | 24M | 106M | 136M |
| Gross Profit | 9M | 24M | 4M | 86M | 129M |
| Operating Income | -25M | -50M | -87M | -4M | 39M |
| Net Income | -27M | -46M | -106M | 78M | 56M |
| EBITDA | -24M | -49M | -81M | -179K | 41M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 42.29 | 1671.22 | 10 |
| Next quarter | 16.02 | -4.47 | 5.0 |
| Current year | 42.61 | -17.85 | 5.5 |
| Next year | 16.56 | -15.82 | 5.0 |
| Weighted average score | 6.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 9.51 | -76.88 | -76.66 | 175.34 | 4.5 |
| Y/Y | 53.25 | -88.76 | -88.42 | 540.88 | 5.5 |
| 3y average | 169.05 | -9.18 | 25.17 | -29.74 | 5.5 |
| 5y average | 111.65 | -41.5 | 30.58 | 7.31 | 6.5 |
| Weighted average score | 5.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |